Karamvir Yadav: EXTEND Trial Shows Improved PFS in Oligometastatic Disease

Karamvir Yadav, Medical Oncologist at Harish Renova Hospital, shared a post on X:

“New evidence for oligometastatic disease.
EXTEND changes the oligometastatic conversation.

MDT + SOC significantly improved PFS across multiple solid tumors — without compromising QoL. 46% reduction in progression/death risk. ctDNA + immune correlatives add biologic credibility.”